A screen for microRNAs involved in the cisplatin resistance in bladder cancer

被引：0
|
作者：
Shindo, Tetsuya [1 ]
Nishiyama, Naotaka [1 ]
Niinuma, Takeshi [2 ]
Maruyama, Reo [1 ]
Kitajima, Hiroshi [2 ]
Kai, Masahiro [2 ]
Tokino, Takashi [3 ]
Masumori, Naoya [1 ]
Suzuki, Hiromu [2 ]
机构：
[1] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido, Japan
[2] Sapporo Med Univ, Sch Med, Dept Mol Biol, Sapporo, Hokkaido, Japan
[3] Sapporo Med Univ, Res Inst Front Med, Med Genome Sci, Sapporo, Hokkaido, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Bladder cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-3039
引用
收藏
页码：894 / 894
页数：1
相关论文
共 50 条
  • [41] The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer
    Hayden, Annette
    Douglas, James
    Sommerlad, Matthew
    Andrews, Lawrence
    Gould, Katherine
    Hussain, Syed
    Thomas, Gareth J.
    Packham, Graham
    Crabb, Simon J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (06) : 806 - 814
  • [42] Tumor-immune interactions and cisplatin resistance in localized muscleinvasive bladder cancer
    De Carvalho, Filipe La Fuente
    Lee, Jihyun
    Bi, Kevin
    Titchen, Breanna
    Stawiski, Konrad
    Park, Jihye
    Garza, Amanda
    Michaud, Daniel
    Guerriero, Jennifer
    Mittendorf, Elizabeth
    Mouw, Kent
    Van Allen, Eliezer
    CANCER RESEARCH, 2024, 84 (06)
  • [43] FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer
    Lu, Yi-Tsung
    Xu, Tong
    Iqbal, Maheen
    Hsieh, Tien-Chan
    Luo, Zhifei
    Liang, Gangning
    Farnham, Peggy J.
    Rhie, Suhn K.
    Goldkorn, Amir
    CANCERS, 2022, 14 (07)
  • [44] SATB1 expression increases resistance of bladder cancer cells to cisplatin
    Choudhary, Shilpa
    Voznesensky, Olga
    Pilbeam, Carol
    Taylor, John A.
    CANCER RESEARCH, 2011, 71
  • [45] Biomarkers of Cisplatin Resistance in Urothelial Bladder Cancer: HMGA2 and Survivin
    Reis, Henning
    Krafft, Ulrich
    Tschirdewahn, Stephan
    Hess, Jochen
    Harke, Nina
    Hadaschik, Boris
    Krege, Susanne
    Nyirady, Peter
    Szendroi, Attila
    Szucs, Miklos
    Modos, Orsolya
    Szekely, Eszter
    Szarvas, Tibor
    Szarvas, Tibor
    LABORATORY INVESTIGATION, 2019, 99
  • [46] Biomarkers of Cisplatin Resistance in Urothelial Bladder Cancer: HMGA2 and Survivin
    Reis, Henning
    Krafft, Ulrich
    Tschirdewahn, Stephan
    Hess, Jochen
    Harke, Nina
    Hadaschik, Boris
    Krege, Susanne
    Nyirady, Peter
    Szendroi, Attila
    Szucs, Miklos
    Modos, Orsolya
    Szekely, Eszter
    Szarvas, Tibor
    Szarvas, Tibor
    MODERN PATHOLOGY, 2019, 32
  • [47] Ultrastructural change due to acquired cisplatin resistance in human bladder cancer cells
    Yoon, SJ
    Park, I
    Kwak, C
    Lee, E
    ONCOLOGY REPORTS, 2003, 10 (05) : 1363 - 1367
  • [48] Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer
    Krafft, Ulrich
    Tschirdewahn, Stephan
    Hess, Jochen
    Harke, Nina N.
    Hadaschik, Boris
    Olah, Csilla
    Krege, Susanne
    Nyirady, Peter
    Szendroi, Attila
    Szucs, Miklos
    Modos, Orsolya
    Szekely, Eszter
    Reis, Henning
    Szarvas, Tibor
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (11) : 810.e7 - 810.e15
  • [49] MicroRNAs: Key Players in Bladder Cancer
    Li, Qi
    Wang, Helei
    Peng, Hourong
    Huang, Qiuping
    Huyan, Ting
    Huang, Qingsheng
    Yang, Hui
    Shi, Junling
    MOLECULAR DIAGNOSIS & THERAPY, 2019, 23 (05) : 579 - 601
  • [50] Aberrant expression of microRNAs in bladder cancer
    Yoshino, Hirofumi
    Seki, Naohiko
    Itesako, Toshihiko
    Chiyomaru, Takeshi
    Nakagawa, Masayuki
    Enokida, Hideki
    NATURE REVIEWS UROLOGY, 2013, 10 (07) : 396 - 404
12345